Live Breaking News & Updates on Neil Warma

Stay updated with breaking news from Neil warma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed Antibodies

ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed Antibodies
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Promis Neurosciences Inc , Exchange Commission , Publishes Study Highlighting Oligomer Selectivity , Neil Warma , Chief Executive Officer , Collective Coordinates , Disease Specific Epitopes , Private Securities Litigation Reform Act , Annual Report , United States Securities , Investor Relations , Marie Fields ,

ProMIS Neurosciences Publishes in the Journal of Biological Chemistry on the Interaction Between Pathogenic Proteins as a Treatment Target for ALS

ProMIS Neurosciences Publishes in the Journal of Biological Chemistry on the Interaction Between Pathogenic Proteins as a Treatment Target for ALS
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Neil Cashman , Promis Neurosciences Inc Nasdaq , Promis Neurosciences Inc , Biological Chemistry , Interaction Between Pathogenic Proteins , Treatment Target , Neurosciences Inc , Neil Warma , Chief Executive Officer , Chief Scientific Officer , Collective Coordinates , Disease Specific Epitopes , Private Securities Litigation Reform Act , Annual Report , Post Effective Amendment , Investor Relations , Marie Fields ,

ProMIS Neurosciences Strengthens Global Intellectual Property Portfolio

CAMBRIDGE, Massachusetts and TORONTO, Ontario, March 11, 2024 (GLOBE NEWSWIRE) ProMIS Neurosciences, Inc. (Nasdaq: PMN), a biotechnology comp. ....

United Kingdom , United States , European Patent Office , Trademark Office , Japanese Patent Office , University Of British Columbia , Promis Neurosciences Inc , United States Patent , Neil Warma , Chief Executive Officer , British Columbia , Collective Coordinates , Disease Specific Epitopes , Private Securities Litigation Reform Act , Annual Report , Post Effective Amendment , Investor Relations , Marie Fields ,

ProMIS Neurosciences to Present at the 2024 BIO CEO & Investor Conference

CAMBRIDGE, Massachusetts and TORONTO, Ontario, Feb. 22, 2024 (GLOBE NEWSWIRE) ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology company focused on the generation and development of therapeutics targeting toxic misfolded proteins in neurodegenerative diseases, today announced that Neil Warma, Chief Executive Officer of ProMIS Neurosciences, will present at the 2024 BIO CEO & Investor Conference, taking place in-person in New York, NY on February 26-27, 2024. Presentation Details: Presen ....

New York , United States , United Kingdom , Marriott Marquis , Promis Neurosciences Inc , Neil Warma , Chief Executive Officer , Plymouth Room , New York Marriott , Collective Coordinates , Disease Specific Epitopes , Investor Relations , Marie Fields , Bio Ceo Investor Conference , Neurodegenerative Diseases , Biotechnology Company , Antibody Therapeutics , Neil Warma , Misfolded Proteins , Chief Executive Officer ,

ProMIS Neurosciences Achieves Milestone in Development of Therapeutic Alpha-Synuclein Vaccine

ProMIS Neurosciences Achieves Milestone in Development of Therapeutic Alpha-Synuclein Vaccine
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Marco Prado , Neil Cashman , Joel Watts , Scott Napper , Tanz Centre For Research , Promis Neurosciences Inc , Department Of Biochemistry , Weston Family Foundation , University Of British Columbia , Infectious Disease Organization , University Of Saskatchewan , Canada Research , American Academy Of Neurology , University Of Western Ontario , University Of Toronto , Achieves Milestone , Therapeutic Alpha Synuclein , Multiple System Atrophy , Lewy Body , Neil Warma , Chief Executive Officer , British Columbia , Scientific Officer , Professor Emeritus ,